Purchases and Sales Made in Q3 2022 in Homology Medicines, Inc. (FIXX)
This table provides information about the institutional ownership of Homology Medicines, Inc. (FIXX) during Q3 2022. The information is specifically focused on institutions that hold shares of Homology Medicines, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-48.6K- 45.59% |
$75.3K - $146K
|
58K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-54.5K- 47.76% |
$84.4K - $164K
|
59.6K
$0
|
|
|
Oct 05, 2022
Q3 2022
|
Vida Ventures Advisors, LLC
|
SELL
|
- |
-74.6K- 9.67% |
$116K - $224K
|
696K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Ergoteles LLC
New York, NY |
SELL
|
- |
-84.4K- 43.67% |
$131K - $254K
|
109K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
SELL
|
- |
-132K- 59.79% |
$204K - $396K
|
88.5K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-157K- 82.51% |
$243K - $472K
|
33.3K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-262K- 36.36% |
$407K - $790K
|
459K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-294K- 41.45% |
$456K - $886K
|
416K
$0
|